About Athersys Athersys is an international biotechnology company engaged in the discovery and development of therapeutic product candidates designed to extend and enhance the quality of human life. The Company is developing its MultiStem cell therapy product, a patented, adult-derived “off-the-shelf” stem cell product, initially for disease indications in the cardiovascular, neurological, inflammatory and immune disease areas, and has several ongoing clinical trials evaluating this potential regenerative medicine product. Athersys has forged strategic partnerships and collaborations with leading pharmaceutical and biotechnology companies, as well as world-renowned research institutions to further develop its platform and products. More information is available at www.athersys.com . Forward-Looking Statements This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that involve risks and uncertainties. These forward-looking statements relate to, among other things, the expected timetable for development of our product candidates, our growth strategy, and our future financial performance, including our operations, economic performance, financial condition, prospects, and other future events. We have attempted to identify forward-looking statements by using such words as “anticipates,” “believes,” “can,” “continue,” “could,” “estimates,” “expects,” “intends,” “may,” “plans,” “potential,” “should,” suggest, “will,” or other similar expressions. These forward-looking statements are only predictions and are largely based on our current expectations. A number of known and unknown risks, uncertainties, and other factors could affect the accuracy of these statements. Some of the more significant known risks that we face that could cause actual results to differ materially from those implied by forward-looking statements are the risks and uncertainties inherent in the process of discovering, developing, and commercializing products that are safe and effective for use as human therapeutics, such as the uncertainty regarding market acceptance of our product candidates and our ability to generate revenues, including MultiStem for the treatment of ischemic stroke, acute myocardial infarction, spinal cord injury and acute respiratory distress syndrome and other disease indications, including graft-versus-host disease. more tips hereThese risks may cause our actual results, levels of activity, performance, or achievements to differ materially from any future results, levels of activity, performance, or achievements expressed or implied by these forward-looking statements.
For the original version including any supplementary images or video, visit http://finance.yahoo.com/news/athersys-receives-fda-agreement-under-103000172.html
Spartans starting outside linebacker Jon Reschke will be out for a “significant time period” with a severe ankle sprain, Spartans coach Mark Dantonio said Tuesday. Reschke, a returning starter, was seen pulling up and favoring his leg after pushing off near the line of scrimmage during the loss to Wisconsin. After missing the Spartans’ opener with an injury, Reschke was one of the team’s best players in its win over Notre Dame. He recorded eight tackles, a forced fumble, an interception and a tackle for loss. Dantonio said he is “optimistic” that Reschke will return this season. Linebacker Riley Bullough’s status also continues to have an uncertain status with an injury. Dantonio said on Tuesday that Bullough is day to day and that the team would make an announcement on his availability ahead of Saturday’s game at Indiana. Bullough, the Spartans’ second-year starting middle linebacker, missed Saturday’s game against Wisconsin with an undisclosed injury. After playing the entire week before against Notre Dame, he came out for Saturday’s game in street clothes. Dantonio said on Tuesday that he had been dealing with an ongoing issue that worsened against Notre Dame.
For the original version including any supplementary images or video, visit http://www.mlive.com/spartans/index.ssf/2016/09/michigan_state_lb_jon_reschke_2.html
Read on to know about this condition in great depth. If you are trying out cosmetics for the first time, be sure to do a patch test on the skin before you try it on your face. Costochondritis is a medical condition that is characterized by inflammation at the junction of a rib and the coastal cartilage that connects it to the sternum. Also, stick to healthier ways of cooking food like grilling, baking, steaming, and boiling. Drugs such as 5-ASA compounds and corticosteroids might be prescribed to reduce the inflammation. Vegetables are an important part of your diet. Although both help to reduce pain, many wants to know which medication has an edge over the other when it comes to pain relief. It is a fact that inflammation of the heart is a serious medical condition, and the degree of its seriousness would only decide the appropriate treatment method. 2 types of bunionsAtrophy of muscles may result from continuous rest.
Swelling can be alleviated by applying ice packs. Read this article to find out about the major possible causes… The orthopaedic may also refer a physiotherapist, who will help the individual regain normal functioning of the ankle through exercise. Resume the physical activity slowly after you are given a thumbs up by the doctor. Bleeding can also occur, causing bruises under the skin. Ankle sprains, tendinitis, as well as minor injuries to the ankle are some of the possible causes of ankle pain. The right treatment at the right time will surely pave way for a speedy recovery. This condition is generally referred as ankle tendinitis.